DLB Dolby Laboratories Inc

  1. Stocks
  2. Industrials
  3. NYSE: DLB

Price (delayed)

$52.13

Market cap

$4.93B

P/E Ratio

20.36

Dividend/share

$1.41

EPS

$2.56

Enterprise value

$4.31B

?
Relative Growth: Rel. Growth: 59
Relative Strength: Rel. Strength: 17
Relative Valuation: Rel. Valuation: 54
Relative Profitability: Rel. Profitability: 80

Dolby Laboratories is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research ...

Highlights
DLB's price to earnings (P/E) is 38% lower than its 5-year quarterly average of 33.3 and 20% lower than its last 4 quarters average of 25.7
The revenue has increased by 3.4% YoY
The debt rose by 23% year-on-year and by 22% since the previous quarter
Dolby Laboratories's quick ratio has decreased by 6% QoQ and by 2.8% YoY
Sector: Industrials
Industry: Specialty Business Services
Website: http://www.dolby.com
Peers: IMAX SSTK BMI

Key stats

What are the main financial stats of DLB

DLB stock price

How has the Dolby Laboratories stock price performed over time
Intraday
-0.55%
1 week
-1.34%
1 month
-4.72%
1 year
-28.57%
YTD
-18.83%
QTD
-13.2%

Financial performance

How have Dolby Laboratories's revenue and profit performed over time
Revenue
$1.36B
Gross profit
$1.19B
Operating income
$252.42M
Net income
$243.65M
Gross margin
87.4%
Net margin
17.9%
The operating margin has declined by 10% year-on-year
The net margin has declined by 8% year-on-year
Dolby Laboratories's operating income has decreased by 7% YoY but it has increased by 2.1% QoQ
The net income has declined by 5% year-on-year

Price vs fundamentals

How does DLB's price correlate with its fundamentals

Growth

What is Dolby Laboratories's growth rate over time

Valuation

What is Dolby Laboratories stock price valuation
DLB P/E details
P/E
20.36
P/B
1.9
P/S
3.64
EV/EBIT
16.04
EV/EBITDA
11.61
EV/Sales
3.16
DLB's price to earnings (P/E) is 38% lower than its 5-year quarterly average of 33.3 and 20% lower than its last 4 quarters average of 25.7
The EPS has declined by 4.1% year-on-year
DLB's price to book (P/B) is 38% lower than its 5-year quarterly average of 3.1 and 24% lower than its last 4 quarters average of 2.5
DLB's price to sales (P/S) is 39% lower than its 5-year quarterly average of 6.0 and 24% lower than its last 4 quarters average of 4.8
The revenue has increased by 3.4% YoY

Efficiency

How efficient is Dolby Laboratories business performance
The return on sales has declined by 11% year-on-year and by 2.5% since the previous quarter
The company's return on equity fell by 10% YoY
Dolby Laboratories's return on assets has decreased by 7% YoY
Dolby Laboratories's return on invested capital has decreased by 4.2% YoY and by 3.4% QoQ

Dividends

What is DLB's dividend history
Dividend details
DPS
$1.41
Dividend yield
2.7%
Payout ratio
55.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Dolby Laboratories financials performed over time
Dolby Laboratories's current ratio has decreased by 6% QoQ
The total liabilities rose by 6% since the previous quarter but it has declined by 3.7% year-on-year
The debt is 98% smaller than the equity
The debt rose by 23% year-on-year and by 22% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.